ArticlePediatric rheumatology online journal2021

Type I interferonopathies with novel compound heterozygous TREX1 mutations in two siblings with different symptoms responded to tofacitinib.

Shiyu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.